GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NervGen Pharma Corp (OTCPK:NGENF) » Definitions » Change In Other Working Capital

NGENF (NervGen Pharma) Change In Other Working Capital : $0.00 Mil (TTM As of Mar. 2025)


View and export this data going back to 2019. Start your Free Trial

What is NervGen Pharma Change In Other Working Capital?

NervGen Pharma's Change In Other Working Capital for the quarter that ended in Mar. 2025 was $0.00 Mil. It means NervGen Pharma's Other Working Capital stayed the same from Dec. 2024 to Mar. 2025 .

NervGen Pharma's Change In Other Working Capital for the fiscal year that ended in Dec. 2024 was $0.00 Mil. It means NervGen Pharma's Other Working Capital increased by $0.00 Mil from Dec. 2023 to Dec. 2024 .

NervGen Pharma Change In Other Working Capital Historical Data

The historical data trend for NervGen Pharma's Change In Other Working Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NervGen Pharma Change In Other Working Capital Chart

NervGen Pharma Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Change In Other Working Capital
Get a 7-Day Free Trial - - - - -

NervGen Pharma Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Change In Other Working Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

NervGen Pharma Change In Other Working Capital Calculation

Change In Other Working Capital is any increase or decrease between periods of other working capital that are not otherwise classified.

Change In Other Working Capital for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

NervGen Pharma Change In Other Working Capital Related Terms

Thank you for viewing the detailed overview of NervGen Pharma's Change In Other Working Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

NervGen Pharma Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NervGen Pharma Corp (OTCPK:NGENF) » Definitions » Change In Other Working Capital
Comparable Companies
NEOE:CYBN TSX:FRX TSX:EPRX XCNQ:METX TSX:TH TSXV:ARCH TSX:MSCL XCNQ:DRUG TSX:MDNA XCNQ:GLAB VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC BNTX XKRX:068270
Traded in Other Exchanges
9UA:Germany NGEN:Canada
Address
112-970 Burrard Street, Unit 1290, Vancouver, BC, CAN, V6Z 2R4
Website
https://www.nervgen.com
NervGen Pharma Corp is a clinical-stage biotech company. The company's principal business activity is the discovery, development, and commercialization of pharmaceutical treatments that enable the nervous system to repair itself following damage, whether due to injury or disease. The company's initial target indication is spinal cord injury. The company's pipeline products include NVG-291 and NVG-300.